Sichuan Goldstone Asia Pharmaceutical Balance Sheet Health
Financial Health criteria checks 5/6
Sichuan Goldstone Asia Pharmaceutical has a total shareholder equity of CN¥2.4B and total debt of CN¥25.0M, which brings its debt-to-equity ratio to 1%. Its total assets and total liabilities are CN¥2.8B and CN¥397.9M respectively. Sichuan Goldstone Asia Pharmaceutical's EBIT is CN¥144.5M making its interest coverage ratio -16.8. It has cash and short-term investments of CN¥531.5M.
Key information
1.0%
Debt to equity ratio
CN¥25.03m
Debt
| Interest coverage ratio | -16.8x |
| Cash | CN¥531.47m |
| Equity | CN¥2.44b |
| Total liabilities | CN¥397.87m |
| Total assets | CN¥2.83b |
Recent financial health updates
Recent updates
Sichuan Goldstone Asia Pharmaceutical's (SZSE:300434) Conservative Accounting Might Explain Soft Earnings
Nov 02
There's Reason For Concern Over Sichuan Goldstone Asia Pharmaceutical Inc.'s (SZSE:300434) Massive 42% Price Jump
Oct 08Sichuan Goldstone Asia Pharmaceutical (SZSE:300434) Has A Pretty Healthy Balance Sheet
Sep 30Sichuan Goldstone Asia Pharmaceutical's (SZSE:300434) Conservative Accounting Might Explain Soft Earnings
May 02Financial Position Analysis
Short Term Liabilities: 300434's short term assets (CN¥1.1B) exceed its short term liabilities (CN¥328.7M).
Long Term Liabilities: 300434's short term assets (CN¥1.1B) exceed its long term liabilities (CN¥69.2M).
Debt to Equity History and Analysis
Debt Level: 300434 has more cash than its total debt.
Reducing Debt: 300434's debt to equity ratio has increased from 0.4% to 1% over the past 5 years.
Debt Coverage: 300434's debt is well covered by operating cash flow (569.9%).
Interest Coverage: 300434 earns more interest than it pays, so coverage of interest payments is not a concern.